British American Tobacco vs Altria
Global tobacco group with established brands and dividends vs Major US tobacco company with steady dividend payments. Which is the better buy for your portfolio in September 2026? Plain-English answer below.
British American Tobacco manages a declining combustible cigarette portfolio while racing to build a smokeless future, and Altria has made a similar pivot after its costly Juul misadventure left it searching for the next act. Both tobacco giants generate enormous cash flows from a shrinking smoker base and use that capital to fund dividends and transformation bets. British American Tobacco vs Altria breaks down the nicotine transition strategies, dividend sustainability, and which balance sheet is better equipped to fund the next decade.
British American Tobacco manages a declining combustible cigarette portfolio while racing to build a smokeless future, and Altria has made a similar pivot after its costly Juul misadventure left it se...
Why It’s Moving
RBC’s renewed bearish call keeps pressure on BTI as BAT leans on next-generation nicotine growth.
- RBC maintained a Sell/Underperform view on September 11, keeping analyst pressure on BTI as investors weigh whether current valuation fully reflects execution risks.
- BAT launched Vuse Essence Bright Tobacco in the UK on September 8, expanding its premium smart-pod lineup and signaling continued investment in reduced-risk nicotine products.
- BTI executives disclosed modest share purchases on September 9, while the upcoming September 29 capital-markets event gives investors a near-term catalyst to assess growth plans and capital allocation.
MO’s income appeal is being tested by falling cigarette volumes and a costly shift toward smokeless nicotine.
- Altria’s U.S. Smokeless Tobacco subsidiary broke ground on a roughly $250 million Hopkinsville, Kentucky, expansion expected to create more than 200 jobs, signaling continued investment in nicotine products beyond traditional cigarettes.
- Director Kathryn McQuade purchased 1,500 Altria shares at $67.62 on September 9, a modest insider-buying signal that contrasts with broader concerns about the company’s long-term volume outlook.
- Recent coverage highlighted Altria’s dividend increase to $1.11 per quarter, but also pointed to cigarette volumes falling about 10% and a payout ratio near 89%, limiting room for error if the decline accelerates.
RBC’s renewed bearish call keeps pressure on BTI as BAT leans on next-generation nicotine growth.
- RBC maintained a Sell/Underperform view on September 11, keeping analyst pressure on BTI as investors weigh whether current valuation fully reflects execution risks.
- BAT launched Vuse Essence Bright Tobacco in the UK on September 8, expanding its premium smart-pod lineup and signaling continued investment in reduced-risk nicotine products.
- BTI executives disclosed modest share purchases on September 9, while the upcoming September 29 capital-markets event gives investors a near-term catalyst to assess growth plans and capital allocation.
MO’s income appeal is being tested by falling cigarette volumes and a costly shift toward smokeless nicotine.
- Altria’s U.S. Smokeless Tobacco subsidiary broke ground on a roughly $250 million Hopkinsville, Kentucky, expansion expected to create more than 200 jobs, signaling continued investment in nicotine products beyond traditional cigarettes.
- Director Kathryn McQuade purchased 1,500 Altria shares at $67.62 on September 9, a modest insider-buying signal that contrasts with broader concerns about the company’s long-term volume outlook.
- Recent coverage highlighted Altria’s dividend increase to $1.11 per quarter, but also pointed to cigarette volumes falling about 10% and a payout ratio near 89%, limiting room for error if the decline accelerates.
Investment Analysis
Pros
- Strong global presence with stable emerging market growth outside the US, supported by leading brands such as Pall Mall and Lucky Strike.
- Focused shifted toward next-generation products like vaping and heated tobacco, with recent acquisitions expanding US and growth market exposure.
- Aggressive share buyback programme and a high dividend yield in the 8% range appeal to income-focused investors.
Considerations
- Faces persistent regulatory scrutiny and health-led policy shifts globally, especially around next-gen products and youth uptake.
- Higher stock price volatility compared to US peers reflects exposure to currency swings and emerging market political risks.
- Heavy debt burden from past acquisitions may constrain flexibility as the industry consolidates and adapts to structural declines.
Altria
MO
Pros
- Dominant US market position behind Marlboro and a large smokeable portfolio, with pricing power and high margins even in a declining market.
- Invests aggressively in next-gen nicotine and cannabis ventures to diversify beyond combustible tobacco, aligning with evolving consumer preferences.
- Consistent, high dividend yield near 7% reflects cash flow stability and management’s shareholder return priorities.
Considerations
- Reliant on the shrinking US cigarette market, with structural declines in smoking rates pressuring long-term volume growth.
- Ongoing legal and regulatory risks, including menthol bans and tighter marketing rules, may accelerate volume erosion and litigation liabilities.
- Valuation appears challenged by limited growth visibility and overhang from stalled international expansion efforts.
British American Tobacco (BTI) Next Earnings Date
BTI’s next earnings release is expected on February 11, 2027. The report should cover the fourth quarter and full fiscal year 2026. The date is based on the company’s established reporting schedule and remains subject to formal confirmation.
Altria (MO) Next Earnings Date
Altria Group (MO) is scheduled to report its next earnings on October 29, 2026, before the market opens. The release will cover the third quarter of fiscal 2026, ending September 30. The date is consistent with Altria’s historical late-October reporting pattern.
British American Tobacco (BTI) Next Earnings Date
BTI’s next earnings release is expected on February 11, 2027. The report should cover the fourth quarter and full fiscal year 2026. The date is based on the company’s established reporting schedule and remains subject to formal confirmation.
Altria (MO) Next Earnings Date
Altria Group (MO) is scheduled to report its next earnings on October 29, 2026, before the market opens. The release will cover the third quarter of fiscal 2026, ending September 30. The date is consistent with Altria’s historical late-October reporting pattern.
Buy BTI or MO in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
